Pure Global
Turkey ÜTS registration 5fb28b2fe6f9e23519905a7b2ed46488

DARZALEX 400 MG/20 ML CONCENTRATE FOR PREPARING SOLUTION FOR INFUSION

TR: DARZALEX 400 MG/20 ML İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN KONSANTRE
Turkey flagTurkey·Pharmaceutical Product·JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ.·Licensed Dec 29, 2017
License details
Product ID (UID)
5fb28b2fe6f9e23519905a7b2ed46488
License Number
2017/958
Barcode
8699593760037
ATC Code
L01FC01
License holder information
License Holder
JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ.
Active ingredient & license information
Active Ingredient (EN)
daratumumab
License Date
Dec 29, 2017
About this record

Access comprehensive regulatory information for DARZALEX 400 MG/20 ML CONCENTRATE FOR PREPARING SOLUTION FOR INFUSION in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 5fb28b2fe6f9e23519905a7b2ed46488 with license number 2017/958and contains active ingredient daratumumab. The license is held by JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI21,000+ Products